Awards and Recognitions

  • August 2018 (also winners in 2015, 2016, 2017)
    PharmaVOICE 100 Most Inspiring People in the Life Sciences Industry

    Altasciences' CEO, Chris Perkin, was named one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine for a fourth consecutive year. This award honors individuals who have inspired and motivated those around them and recognizes the positive impact they have had on the industry through their leadership, influence as a corporate leader, and innovative actions.

  • July 2018
    Top 10 CROs in 2018

    Altasciences was recognized by Pharma Tech Outlook magazine as one of the Top 10 CROs in 2018 in their annual listing of companies that are at the forefront of tackling customer challenges.

  • April 2018
    Gamechangers Healthcare / Pharmaceutical / Biotech and Medtech Awards 2018

    Altasciences' CEO, Chris Perkin, was named Gamechanger of the Year. The award recognizes individuals and organizations for their critical contributions and services to the industry, by rewarding those who have played a significant role in increasing the efficiency as well as performance of the industry as a whole. These exemplary performers, innovators and visionaries (the Gamechangers) in the healthcare industry epitomize the best that the healthcare industry has to offer and their work sets an example for consistent effort, devotion and doing extraordinary service to humanity.

  • April 2018
    Gamechangers Healthcare / Pharmaceutical / Biotech and Medtech Awards 2018

    Altasciences was named Full-Service Early Stage Clinical Research Provider of the Year. The award recognizes individuals and organizations for their critical contributions and services to the industry, by rewarding those who have played a significant role in increasing the efficiency as well as performance of the industry as a whole. These exemplary performers, innovators and visionaries (the Gamechangers) in the healthcare industry epitomize the best that the healthcare industry has to offer and their work sets an example for consistent effort, devotion and doing extraordinary service to humanity.

  • April 2018
    Clinical and Research Excellence Awards by Pharma Intelligence (CARE)

    Altasciences was named as a finalist in the Most Successful Early Phase Research (Preclinical & Phase I) category. Our nomination highlighted our innovative cannabis research and detailed the 2017 first-in-human, safety and tolerability study we conducted with PPP001, the world’s first cannabis extract being delivered by inhalation and developed as a drug for regulatory approval in Canada and the United States. It is targeted for breakthrough and advanced cancer pain.

Pages